Anti-SAP Reference Antibody(De

APCS（SAP）分子特征、免疫调控机制与相关疾病及靶向治疗进展

能力，并抑制纤维细胞分化。因此，SAP在纤维化疾病、淀粉样蛋白病、心血管疾病、神经精神疾病、呼吸系统疾病及微生物感染等多种疾病的发病机制与治疗中具有重要意义。 APCS的靶向治疗 Dezamizumab（GSK2398852）是葛兰素史克（GSK）开发的靶向 APCS 单克隆抗体，用于炎症相关疾病干预。这类靶向抗体的前期筛选、体外功能验证，均离不开标准化重组蛋白与抗体作为基础实验材料；该单抗可特异性结合 SAP 蛋白，阻断其与淀粉样纤维的相互作用，促进淀粉样纤维清除并修复脏器损伤。在1期临床研究中

Isolation of Anti-Hapten Specific Antibody Fragments from Combinatorial Libraries

system unless presented as an epitope conjugated to a suitable immunogenic carrier protein, such as bovine thyroglobulin. The principal interest in anti-hapten Abs is as detection molecules for use in diagnostic assays. These typically use dipstick (qualitative

Assays for Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC) and Reverse ADCC (Redirected Cytotoxicity) in Human Natural Killer Cells

immunecomplexed IgG and therefore target cells that, not recognized spontaneously by NK cells, are sensitized with anti-target cell antibodies (Abs) of the IgG class. The two types of cytotoxicity elicited are referred to as “spontaneous” and “Ab-dependent’ cell